From November 5 to 7, 2019, CPhI Worldwide Europe was held in the Exhibition Centre Frankfurt, Germany. Dong Jianhua, executive director of Sinochem Pharmaceutical Co., Ltd., led a delegation to attend the exhibition.
Sinochem Pharmaceutical has been focusing on the field of medical health for a long time, and its main business involves medicine and medical devices. After over ten years of development, it has grown into a dual core driven pharmaceutical integrated enterprise, whose business covers international trade, customized processing, R & D and production of pharmaceutical intermediates, APIs, preparations, TCM and other related pharmaceutical products, as well as warehousing logistics services and domestic distribution of orthopedic and cardiovascular medical devices. As a well-known enterprise in the field of medicine domestically, Sinochem Pharmaceutical has a professional pharmaceutical business team and possesses business qualifications of GSP and medical equipment, serving global customers in more than 100 countries and regions.
The three-day exhibition attracted high-quality enterprises and customers worldwide to participate and negotiate. Sinochem Pharmaceutical carried out a comprehensive brand display and image publicity, and attracted new and old customers worldwide to negotiate.
In the process of communication, exhibitior emphasized on Sinochem Pharmaceutical’s main products and strategic direction, discussed the industry development trend, and reached deal intentions or cooperation plans with customers in many fields. The atmosphere on site was enthusiastic and good results were achieved in the exhibition.
Sinochem Pharmaceutical is a subsidiary of Sinochem International. Sinochem International, the Chemical flagship of Sinochem Group, is an international large-scale state-owned listed enterprise with core competitiveness in agrochemicals, intermediates and new materials, polymer additives. It provides products and services to over 100 countries and regions.